Global Coronary Stents Market Witness a Robust Expansion of US$ 6.4 Billion at a CAGR of 2.4% by 2024

Global Coronary Stents Market is expected to reach USD 6.4 billion by 2024 from USD 5.3 billion in 2016, at a CAGR of 2.4% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Request for Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=coronary-stents-market

The global coronary stents market is segmented on the basis of product type, portability, application, end-user, and geography.

Browse Full Report with Details TOC @ http://databridgemarketresearch.com/reports/coronary-stents-market/

On the basis of type, the global coronary stents market is segmented into dual therapy stent, bioresorbable vascular scaffold (BVS), drug eluting stent (DES), bio-engineered stent, bare metal stent.

On the basis of application, the coronary stents market is segmented into coronary artery disease, and peripheral artery disease.

The market is also segmented on the basis of end-user into hospitals, and cardiac centres.

Based on geography, the market is segmented into five geographical regions:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa
• Rest of the World.

The geographical regions are further segmented into major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.

The Global Coronary Stent Market Report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.

Speak to Analyst: http://databridgemarketresearch.com/speak-to-analyst/?dbmr=coronary-stents-market

Some of the major players operating in this market are
• Abbott Vascular
• SciTech
• Boston Scientific Corporation
• Minvasys
• Medinol Ltd
• iVascular SLU
• Elixir Medical Corporation
• Inspire MD
• Stentys SA
• Hexacath
• Medtronic
• Andramed GmbH
• Cordis Corporation
• Orbusneich
• Eurocor GmbH
• Comed B.V.
• Endocor GmbH
• MicroPort Scientific Corporation
• Amaranth Medical, Inc.
• Terumo Corporation
• Degania Silicone Ltd.
• Meril Life Sciences Pvt. Ltd.
• InSitu Technologies Inc.
• Alvimedica
• Biotronik SE & Co. KG
• AMG International GmbH
• Arthesys
• Lepu Medical
• Translumina GmbH
• Accura
• Svelte Medical
• B. Braun Melsungen AG
• Eucatech AG

Inquiry before Buying @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=coronary-stents-market

Table Of Content:
1. INTRODUCTION
1.1. OVERVIEW OF THE GLOBAL CORONARY STENTS MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
1.2.3. STAKEHOLDERS
2. RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL CORONARY STENTS MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6. PORTER’S FIVE FORCES MATRIX
2.3. GLOBAL CORONARY STENTS MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. GLOBAL CORONARY STENTS MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.2. RESTRAINTS
4.3.3. OPPOTUNITIES
4.3.4. THREATS
4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5. GLOBAL CORONARY STENTS MARKET, BY TYPE
5.1. OVERVIEW
5.2. DUAL THERAPY STENT
5.3. BIORESORBABLE VASCULAR SCAFFOLD
5.4. DRUG ELUTING STENT (DES)
5.4.1. PACLITAXEL
5.4.2. IMUS-BASED DRUGS
5.5. BIO-ENGINEERED STENT
5.6. BARE METAL STENT
6. GLOBAL CORONARY STENTS MARKET, BY ABSORPTION RATE
6.1. SLOW-ABSORPTION DES
6.2. FAST-ABSORPTION (DES)
7. GLOBAL CORONARY STENTS MARKET, BY MATERIAL
7.1. OVERVIEW
7.2. STAINLESS STEEL
7.3. COBALT ALLOY METAL
7.4. GOLD
7.5. TANTALUM
7.6. NITINOL
7.7. POLYMERS
8. GLOBAL CORONARY STENTS MARKET, BY RATE
8.1. OVERVIEW
8.2. SLOW-ABSORPTION STENTS
8.3. FAST-ABSORPTION STENTS
9. GLOBAL CORONARY STENTS MARKET, BY APPLICATION
9.1. CORONARY ARTERY DISEASE
9.2. PERIPHERAL ARTERY DISEASE
10. GLOBAL CORONARY STENTS MARKET, BY END USER
10.1. HOSPITALS
10.2. CARDIAC CENTERS
10.3. OTHERS
11. GLOBAL CORONARY STENTS MARKET, BY GEOGRAPHY
11.1. COUNTRYWISE CORONARY STENTS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
11.1.1. NORTH AMERICA
11.1.1.1. U.S.
11.1.1.2. CANADA
11.1.1.3. MEXICO
11.1.2. EUROPE
11.1.2.1. GERMANY
11.1.2.2. FRANCE
11.1.2.3. U.K.
11.1.2.4. ITALY
11.1.2.5. SPAIN
11.1.2.6. RUSSIA
11.1.2.7. TURKEY
11.1.2.8. BELGIUM
11.1.2.9. NETHERLANDS
11.1.2.10. SWITZERLAND
11.1.2.11. REST OF EUROPE
11.1.3. ASIA-PACIFIC (APAC)
11.1.3.1. JAPAN
11.1.3.2. CHINA
11.1.3.3. SOUTH KOREA
11.1.3.4. INDIA
11.1.3.5. AUSTRALIA
11.1.3.6. SINGAPORE
11.1.3.7. THAILAND
11.1.3.8. MALAYSIA
11.1.3.9. INDONESIA
11.1.3.10. PHILIPPINES
11.1.3.11. REST OF APAC
11.1.4. SOUTH AMERICA
11.1.4.1. BRAZIL
11.1.4.2. REST OF SOUTH AMERICA
11.1.5. MIDDLE EAST AND AFRICA
11.1.5.1. SOUTH AFRICA
11.1.5.2. REST OF MIDDLE EAST AND AFRICA
11.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
12. GLOBAL CORONARY STENTS MARKET: COMPETITIVE LANDSCAPE
12.1. GLOBAL CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
12.2. U.S. CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
12.3. EUROPE CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
12.4. APAC CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
12.5. SOUTH AMERICA CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
12.6. MIDDLE EAST AND AFRICA CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
12.7. MERGERS & ACQUISITIONS
12.8. NEW PRODUCT DEVELOPMENT & APPROVALS
12.9. EXPANSIONS
12.10. REGULATORY CHANGES
12.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
13. GLOBAL CORONARY STENTS MARKET, COMPANY PROFILES
13.1. ABBOTT VASCULAR
13.1.1. OVERVIEW
13.1.2. SWOT ANALYSIS
13.1.3. PRODUCT PORTFOLIO
13.1.4. REVENUE ANALYSIS
13.1.5. ANALYSTS VIEW
13.2. SCITECH
13.2.1. OVERVIEW
13.2.2. SWOT ANALYSIS
13.2.3. PRODUCT PORTFOLIO
13.2.4. REVENUE ANALYSIS
13.2.5. ANALYSTS VIEW
13.3. BOSTON SCIENTIFIC CORPORATION
13.3.1. OVERVIEW
13.3.2. SWOT ANALYSIS
13.3.3. PRODUCT PORTFOLIO
13.3.4. REVENUE ANALYSIS
13.3.5. ANALYST VIEW
13.4. MEDINOL LTD
13.4.1. OVERVIEW
13.4.2. SWOT ANALYSIS
13.4.3. PRODUCT PORTFOLIO
13.4.4. REVENUE ANALYSIS
13.4.5. ANALYSTS VIEW
13.5. IVASCULAR SLU
13.5.1. OVERVIEW
13.5.2. SWOT ANALYSIS
13.5.3. PRODUCT PORTFOLIO
13.5.4. REVENUE ANALYSIS
13.5.5. ANALYSTS VIEW
13.6. STENTYS SA
13.6.1. OVERVIEW
13.6.2. SWOT ANALYSIS
13.6.3. PRODUCT PORTFOLIO
13.6.4. REVENUE ANALYSIS
13.6.5. ANALYSTS VIEW
13.7. ELIXIR MEDICAL CORPORATION
13.7.1. OVERVIEW
13.7.2. SWOT ANALYSIS
13.7.3. PRODUCT PORTFOLIO
13.7.4. REVENUE ANALYSIS
13.7.5. ANALYSTS VIEW
13.8. INSPIRE MD
13.8.1. OVERVIEW
13.8.2. SWOT ANALYSIS
13.8.3. PRODUCT PORTFOLIO
13.8.4. REVENUE ANALYSIS
13.8.5. ANALYSTS VIEW
13.9. HEXACATH
13.9.1. OVERVIEW
13.9.2. SWOT ANALYSIS
13.9.3. PRODUCT PORTFOLIO
13.9.4. REVENUE ANALYSIS
13.9.5. ANALYSTS VIEW
13.10. MEDTRONIC
13.10.1. OVERVIEW
13.10.2. SWOT ANALYSIS
13.10.3. PRODUCT PORTFOLIO
13.10.4. REVENUE ANALYSIS
13.10.5. ANALYSTS VIEW
13.11. ORBUSNEICH
13.11.1. OVERVIEW
13.11.2. SWOT ANALYSIS
13.11.3 PRODUCT PORTFOLIO
13.11.4 REVENUE ANALYSIS
13.11.5 ANALYSTS VIEW
13.12. ANDRAMED GMBH
13.12.1. OVERVIEW
13.12.2. SWOT ANALYSIS
13.12.3. PRODUCT PORTFOLIO
13.12.4. REVENUE ANALYSIS
13.12.5. ANALYSTS VIEW
13.13. CORDIS CORPORATION
13.13.1. OVERVIEW
13.13.2. SWOT ANALYSIS
13.13.3. PRODUCT PORTFOLIO
13.13.4. REVENUE ANALYSIS
13.13.5. ANALYSTS VIEW
13.14. ENDOCOR GMBH
13.14.1. OVERVIEW
13.14.2. SWOT ANALYSIS
13.14.3. PRODUCT PORTFOLIO
13.14.4. REVENUE ANALYSIS
13.14.5. ANALYSTS VIEW
13.15. EUROCOR GMBH
13.15.1. OVERVIEW
13.15.2. SWOT ANALYSIS
13.15.3. PRODUCT PORTFOLIO
13.15.4. REVENUE ANALYSIS
13.15.5. ANALYSTS VIEW
13.16. COOK MEDICAL.
13.16.1. OVERVIEW
13.16.2. SWOT ANALYSIS
13.16.3. PRODUCT PORTFOLIO
13.16.4. REVENUE ANALYSIS
13.16.5. ANALYSTS VIEW
13.17. MICROPORT SCIENTIFIC CORPORATION
13.17.1. OVERVIEW
13.17.2. SWOT ANALYSIS
13.17.3. PRODUCT PORTFOLIO
13.17.4. REVENUE ANALYSIS
13.17.5. ANALYSTS VIEW
13.18. DEGANIA SILICONE LTD.
13.18.1. OVERVIEW
13.18.2. SWOT ANALYSIS
13.18.3. PRODUCT PORTFOLIO
13.18.4. REVENUE ANALYSIS
13.18.5. ANALYSTS VIEW
13.19. TERUMO CORPORATION
13.19.1. OVERVIEW
13.19.2. SWOT ANALYSIS
13.19.3. PRODUCT PORTFOLIO
13.19.4. REVENUE ANALYSIS
13.19.5. ANALYSTS VIEW
13.20. MERIL LIFE SCIENCES PVT. LTD.
13.20.1. OVERVIEW
13.20.2. SWOT ANALYSIS
13.20.3. PRODUCT PORTFOLIO
13.20.4. REVENUE ANALYSIS
13.20.5. ANALYSTS VIEW
13.21. ALVIMEDICA
13.21.1. OVERVIEW
13.21.2. SWOT ANALYSIS
13.21.3. PRODUCT PORTFOLIO
13.21.4. REVENUE ANALYSIS
13.21.5. ANALYSTS VIEW
13.22. ELIXIR MEDICAL CORPORATION
13.22.1. OVERVIEW
13.22.2. SWOT ANALYSIS
13.22.3. PRODUCT PORTFOLIO
13.22.4. REVENUE ANALYSIS
13.22.5. ANALYSTS VIEW
13.23. INSITU TECHNOLOGIES INC.
13.23.1. OVERVIEW
13.23.2. SWOT ANALYSIS
13.23.3. PRODUCT PORTFOLIO
13.23.4. REVENUE ANALYSIS
13.23.5. ANALYSTS VIEW
13.24. BIOTRONIK SE & CO. KG
13.24.1. OVERVIEW
13.24.2. SWOT ANALYSIS
13.24.3. PRODUCT PORTFOLIO
13.24.4. REVENUE ANALYSIS
13.24.5. ANALYSTS VIEW
13.25. AMG INTERNATIONAL GMBH
13.25.1. OVERVIEW
13.25.2. SWOT ANALYSIS
13.25.3. PRODUCT PORTFOLIO
13.25.4. REVENUE ANALYSIS
13.25.5. ANALYSTS VIEW
13.26. ARTHESYS
13.26.1. OVERVIEW
13.26.2. SWOT ANALYSIS
13.26.3. PRODUCT PORTFOLIO
13.26.4. REVENUE ANALYSIS
13.26.5. ANALYSTS VIEW
13.27. TRANSLUMINA GMBH
13.27.1. OVERVIEW
13.27.2. SWOT ANALYSIS
13.27.3. PRODUCT PORTFOLIO
13.27.4. REVENUE ANALYSIS
13.27.5. ANALYSTS VIEW
13.28. LEPU MEDICAL
13.28.1. OVERVIEW
13.28.2. SWOT ANALYSIS
13.28.3. PRODUCT PORTFOLIO
13.28.4. REVENUE ANALYSIS
13.28.5. ANALYSTS VIEW
13.29. ACCURA
13.29.1. OVERVIEW
13.29.2. SWOT ANALYSIS
13.29.3. PRODUCT PORTFOLIO
13.29.4. REVENUE ANALYSIS
13.29.5. ANALYSTS VIEW
13.30. CELONOVA BIOSCIENCES, INC.
13.30.1. OVERVIEW
13.30.2. SWOT ANALYSIS
13.30.3. PRODUCT PORTFOLIO
13.30.4. REVENUE ANALYSIS
13.30.5. ANALYSTS VIEW
13.31. MINVASYS
13.31.1. OVERVIEW
13.31.2. SWOT ANALYSIS
13.31.3. PRODUCT PORTFOLIO
13.31.4. REVENUE ANALYSIS
13.31.5. ANALYSTS VIEW
13.32. SVELTE MEDICAL
13.32.1. OVERVIEW
13.32.2. SWOT ANALYSIS
13.32.3. PRODUCT PORTFOLIO
13.32.4. REVENUE ANALYSIS
13.32.5. ANALYSTS VIEW
13.33. B. BRAUN MELSUNGEN AG
13.33.1. OVERVIEW
13.33.2. SWOT ANALYSIS
13.33.3. PRODUCT PORTFOLIO
13.33.4. REVENUE ANALYSIS
13.33.5. ANALYSTS VIEW
13.34. EUCATECH AG
13.34.1. OVERVIEW
13.34.2. SWOT ANALYSIS
13.34.3. PRODUCT PORTFOLIO
13.34.4. REVENUE ANALYSIS
13.34.5. ANALYSTS VIEW
13. APPENDIX
14. ABOUT DATA BRIDGE MARKET RESEARCH

Related Report

Global Vital Signs Monitoring Market – Industry Trends and Forecast to 2024

Global Vital Signs Monitoring Market, By Product (Blood Pressure Monitoring (Aneroid BP Monitors, Automated BP Monitors, Ambulatory BP Monitors, BP Device Accessories), Pulse Oximeter (Tabletop/Bedside Pulse Oximeter, Fingertip, Handheld, Wrist Worn, Pediatric Pulse Oximeter, Pulse Oximeter Accessories), Temperature Monitoring Devices (Mercury-Filled Thermometers, Digital Thermometers, Infrared Thermometers, Temperature Strips, Temperature Monitoring Devices Accessories)), By Type (Standalone, Portable), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Online Websites, Others), By End Users (Hospitals & Clinics, Ambulatory Surgery Centers, Home Healthcare, Diagnostic Center, Others), By Geography (North America, Europe, Asia Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

http://databridgemarketresearch.com/reports/global-vital-signs-monitoring-devices-market/

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.